AGEX THERAPEUTICS INC (AGE) Stock Price & Overview
NYSEARCA:AGE • US00848H2076
Current stock price
The current stock price of AGE is 11.1 USD. Today AGE is down by -11.9%. In the past month the price decreased by -19.01%. In the past year, price decreased by -52.4%.
AGE Key Statistics
- Market Cap
- 421.245M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.37
- Dividend Yield
- N/A
AGE Stock Performance
AGE Stock Chart
AGE Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to AGE. When comparing the yearly performance of all stocks, AGE is a bad performer in the overall market: 91.49% of all stocks are doing better.
AGE Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AGE. Both the profitability and financial health of AGE have multiple concerns.
AGE Earnings
AGE Forecast & Estimates
AGE Groups
Sector & Classification
AGE Financial Highlights
Over the last trailing twelve months AGE reported a non-GAAP Earnings per Share(EPS) of -0.37. The EPS decreased by -42.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -115.07% | ||
| ROE | -166.86% | ||
| Debt/Equity | 0.08 |
AGE Ownership
AGE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.07 | 369.265B | ||
| AMGN | AMGEN INC | 15.24 | 187.564B | ||
| GILD | GILEAD SCIENCES INC | 15.81 | 173.439B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.63 | 111.445B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.3 | 80.543B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.73 | 42.286B | ||
| INSM | INSMED INC | N/A | 35.012B | ||
| NTRA | NATERA INC | N/A | 29.477B | ||
| BIIB | BIOGEN INC | 11.03 | 26.026B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.91 | 24.756B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.643B | ||
| MRNA | MODERNA INC | N/A | 19.431B | ||
| INCY | INCYTE CORP | 12.53 | 19.091B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AGE
Company Profile
AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. The company is headquartered in Alameda, California and currently employs 5 full-time employees. The company went IPO on 2018-11-29. The firm is focused on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. The firm's proprietary technology, based on telomerase-mediated cellular immortality and regenerative biology, allows utilizing telomerase-expressing regenerative pluripotent stem cells (PSCs) for the manufacture of cell-based therapies. Its cell-based therapeutic candidates in development are AGEX-BAT1 and AGEX-VASC1. AGEX-BAT1 is a cell therapy product candidate in the discovery stage of development utilizing PSC-derived brown adipocytes for the treatment of certain age-related metabolic disorders such as Type II (adult-onset) diabetes and obesity. AGEX-VASC1 is a cell-based therapy comprised of young regenerative vascular-forming cells. AGEX-VASC1 may restore vascular support in aged ischemic tissues such as in peripheral vascular disease and ischemic heart disease.
Company Info
IPO: 2018-11-29
AGEX THERAPEUTICS INC
1101 Marina Village Parkway, Suite 201
Alameda CALIFORNIA 94501 US
CEO: Michael D. West
Employees: 5
Phone: 15106718370
AGEX THERAPEUTICS INC / AGE FAQ
Can you describe the business of AGEX THERAPEUTICS INC?
AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. The company is headquartered in Alameda, California and currently employs 5 full-time employees. The company went IPO on 2018-11-29. The firm is focused on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. The firm's proprietary technology, based on telomerase-mediated cellular immortality and regenerative biology, allows utilizing telomerase-expressing regenerative pluripotent stem cells (PSCs) for the manufacture of cell-based therapies. Its cell-based therapeutic candidates in development are AGEX-BAT1 and AGEX-VASC1. AGEX-BAT1 is a cell therapy product candidate in the discovery stage of development utilizing PSC-derived brown adipocytes for the treatment of certain age-related metabolic disorders such as Type II (adult-onset) diabetes and obesity. AGEX-VASC1 is a cell-based therapy comprised of young regenerative vascular-forming cells. AGEX-VASC1 may restore vascular support in aged ischemic tissues such as in peripheral vascular disease and ischemic heart disease.
Can you provide the latest stock price for AGEX THERAPEUTICS INC?
The current stock price of AGE is 11.1 USD. The price decreased by -11.9% in the last trading session.
What is the dividend status of AGEX THERAPEUTICS INC?
AGE does not pay a dividend.
What is the ChartMill rating of AGEX THERAPEUTICS INC stock?
AGE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How is the valuation of AGEX THERAPEUTICS INC (AGE) based on its PE ratio?
AGEX THERAPEUTICS INC (AGE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.37).
Should I buy AGE stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AGE.
Can you provide the upcoming earnings date for AGEX THERAPEUTICS INC?
AGEX THERAPEUTICS INC (AGE) will report earnings on 2024-05-13, after the market close.